12.45

0.48% 0.06

Core Laboratories Inc (CLB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$12.39

Aprire:

$12.4

Volume 24 ore:

474.99K

Relative Volume:

0.58

Capitalizzazione di mercato:

$571.26M

Reddito:

$524.73M

Utile/perdita netta:

$31.70M

Rapporto P/E:

18.82

EPS:

0.6617

Flusso di cassa netto:

$22.47M

1 W Prestazione:

+9.69%

1M Prestazione:

+7.79%

6M Prestazione:

-32.92%

1 anno Prestazione:

+17.45%

Intervallo 1D:

$12.29

$12.85

Intervallo di 1 settimana:

$11.37

$12.85

Portata 52W:

$9.79

$20.36

Core Laboratories Inc Stock (CLB) Company Profile

Nome

Core Laboratories Inc

Settore

Energy (257)

Industria

Oil & Gas Equipment & Services (52)

Telefono

713-328-2673

Indirizzo

6316 WINDFERN ROAD, HOUSTON

Dipendente

3,300

Cinguettio

@corelabcompany

Prossima data di guadagno

2026-07-29

Ultimi documenti SEC

CLB's Discussions on Twitter

Compare CLB vs SLB, BKR, FTI, HAL, TS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLB Core Laboratories Inc	12.45	571.26M	524.73M	31.70M	22.47M	0.6617
SLB Slb Ltd	53.77	78.07B	35.91B	3.38B	4.41B	2.2806
BKR Baker Hughes Company	64.82	63.81B	27.89B	3.15B	2.29B	3.1363
FTI Technipfmc Plc	78.61	29.52B	10.17B	1.08B	1.34B	2.6138
HAL Halliburton Co	34.42	27.73B	22.37B	1.61B	1.73B	1.9091
TS Tenaris Sa Adr	53.58	26.83B	12.19B	2.03B	1.87B	3.8072

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-12	Aggiornamento	Citigroup	Sell → Neutral
2023-06-30	Downgrade	Citigroup	Neutral → Sell
2023-04-18	Downgrade	BofA Securities	Neutral → Underperform
2023-01-09	Aggiornamento	BofA Securities	Underperform → Neutral
2022-10-07	Aggiornamento	Citigroup	Sell → Neutral
2022-09-26	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2022-04-18	Downgrade	Piper Sandler	Neutral → Underweight
2021-10-18	Downgrade	BofA Securities	Neutral → Underperform
2021-07-09	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-06-14	Downgrade	Citigroup	Neutral → Sell
2020-12-18	Downgrade	JP Morgan	Neutral → Underweight
2020-11-11	Reiterato	Cowen	Market Perform
2020-10-13	Aggiornamento	BofA Securities	Underperform → Neutral
2020-09-29	Aggiornamento	ABN Amro	Sell → Hold
2020-07-16	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2020-04-13	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2020-03-09	Downgrade	BofA/Merrill	Buy → Underperform
2020-03-09	Downgrade	Evercore ISI	Outperform → In-line
2020-01-31	Reiterato	Cowen	Market Perform
2020-01-30	Ripresa	Johnson Rice	Buy
2020-01-14	Iniziato	Bernstein	Mkt Perform
2020-01-02	Downgrade	Stifel	Buy → Hold
2019-12-31	Reiterato	Cowen	Market Perform
2019-07-10	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-02-25	Aggiornamento	Tudor Pickering	Hold → Buy
2018-12-19	Downgrade	Credit Suisse	Outperform → Neutral
2018-12-11	Downgrade	JP Morgan	Overweight → Neutral
2018-11-16	Aggiornamento	Guggenheim	Neutral → Buy
2018-11-01	Aggiornamento	ABN Amro	Sell → Buy
2018-10-29	Reiterato	Cowen	Market Perform

Mostra tutto

Core Laboratories Inc Borsa (CLB) Ultime notizie

Aug 14, 2026

Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan

Aug 14, 2026

Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan

Aug 14, 2026

Aug 13, 2026

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - marketbeat.com

Aug 13, 2026